You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rituximab, ANCA, vasculitis, lupus,

Showing 1 - 25 of 3,026
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)

Recruiting
  • ANCA Associated Vasculitis
  • Beijing, China
    Peking Union Medical College Hospital
Jul 19, 2023

Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia

Not yet recruiting
  • Granulomatosis With Polyangiitis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Dec 29, 2022

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing

Recruiting
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • ANCA-Associated Glomerulonephritis
  • Chongqing, Chongqing, China
    Children's Hospital of Chongqing Medical University
Jul 23, 2023

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared

Recruiting
  • ANCA-associated Vasculitis
  • +2 more
    • Calgary, Alberta, Canada
    • +8 more
    Jan 27, 2023

    ANCA Associated Vasculitis Trial in Netherlands (Rituximab, endoxan, Methylprednisolone)

    Recruiting
    • ANCA Associated Vasculitis
    • Leiden, Zuid-Holland, Netherlands
    • +3 more
    May 16, 2022

    Invasive Pneumococcal Infection Trial in Paris (PCV13, PPV23, Rituximab)

    Completed
    • Invasive Pneumococcal Infection
    • PCV13
    • +2 more
    • Paris, France
      Pôle de Médecine Interne, Centre de référence " Maladies systémi
    Jun 7, 2022

    ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)

    Active, not recruiting
    • ANCA Associated Vasculitis
    • Granulomatosis With Polyangiitis
    • Cambridge, United Kingdom
    • +5 more
    Feb 21, 2022

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Trial in Boston (Rituximab)

    Recruiting
    • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 28, 2021

    Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)

    Recruiting
    • Systemic Lupus Erythematosus (SLE)
    • +5 more
    • BRL-301
    • Shanghai, Shanghai, China
      Shanghai ChangZheng hospital
    May 7, 2023

    Granulomatosis With Polyangiitis, Microscopic Polyangiitis Trial in Boston (Glucocorticoids, Rituximab)

    Completed
    Has Results
    • Granulomatosis With Polyangiitis
    • Microscopic Polyangiitis
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jun 23, 2021

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis Trial in Worldwide

    Completed
    Has Results
    • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    • +2 more
    • Los Angeles, California
    • +37 more
    Feb 18, 2022

    Giant Cell Arteritis, Takayasu Arteritis, Cogan Syndrome Trial in Cambridge, Glasgow, London (Rituximab, Infliximab,

    Recruiting
    • Giant Cell Arteritis
    • +8 more
    • Rituximab
    • +2 more
    • Cambridge, United Kingdom
    • +2 more
    Dec 9, 2021

    ANCA-associated Vasculitides Trial in Paris (rituximab, Placebo)

    Completed
    • ANCA-associated Vasculitides
    • Paris, France
      Hopital cochin
    Apr 16, 2021

    Regimen in ANCA-associated Vasculitis

    Terminated
    • Granulomatosis, Wegener's
    • Microscopic Polyangiitis
    • blood specimen
    • Lyon, France
    • +3 more
    Nov 12, 2020

    Urinary T Lymphocytes Predict Renal Flares in Inactive

    Completed
    • Glomerulonephritis Acute
    • Analysis of urine samples with flow cytometry
    • Berlin, Germany
    • +1 more
    Mar 8, 2022

    ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis Trial (Pioglitazone (ACTOS®),

    Not yet recruiting
    • ANCA Associated Vasculitis
    • +2 more
    • Pioglitazone (ACTOS®)
    • Placebo of Pioglitazone
    • (no location specified)
    Jul 7, 2023

    ANCA Associated Vasculitis Trial in Bordeaux (blood sample, urine sample)

    Recruiting
    • ANCA Associated Vasculitis
    • blood sample
    • urine sample
    • Bordeaux, France
      CHU de Bordeaux - Service d'Immunologie et Immunogénétique
    Dec 13, 2022

    ANCA Associated Vasculitis, Microscopic Polyangiitis, Churg-Strauss Syndrome Trial in United Kingdom (Hydroxychloroquine,

    Recruiting
    • ANCA Associated Vasculitis
    • +3 more
    • Cardiff, United Kingdom
    • +8 more
    Mar 17, 2022

    Vasculitis Trial in Worldwide (Placebo, CCX168)

    Completed
    Has Results
    • Vasculitis
    • Feldkirch, Austria
    • +43 more
    Jul 10, 2020

    Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

    Recruiting
    • Rheumatoid Arthritis
    • +8 more
    • COVID-19 vaccine
    • Montréal, Quebec, Canada
    • +1 more
    Jan 13, 2023

    Vasculitis Trial in Assiut (Ibuprofen, Prednisone, Methotrexate)

    Unknown status
    • Vasculitis
    • Assiut, Upper Egypt, Egypt
      Assiut University Pediatric Hospital
    Feb 12, 2021

    ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

    Recruiting
    • ANCA-associated Vasculitis
    • Maintenance Therapy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 20, 2023

    ANCA Associated Vasculitis Trial in Chapel Hill (ENUMERATION OF CD5+ B Cells)

    Recruiting
    • ANCA Associated Vasculitis
    • ENUMERATION OF CD5+ B Cells
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Nov 29, 2021

    Subclinical Cytomegalovirus Reactivation in Acute

    Recruiting
    • ANCA Associated Vasculitis
      • Birmingham, West Midlands, United Kingdom
        University Hospitals Birmingham
      Jan 15, 2023

      Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease Trial in France (Discontinuation (or not

      Recruiting
      • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
      • End Stage Renal Disease
      • Discontinuation (or not initiation) of Immunosuppressive Therapy
      • Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®
      • Amiens, France
      • +54 more
      Jan 6, 2023